Clinical Trial Update: Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization [NA]

View source ↗

Summary

A Massachusetts General Hospital trial studying pain reduction and ovarian perfusion after uterine fibroid embolization was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abnormal Uterine Bleeding
• Uterine Fibroids

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Uterine Bleeding, Uterine Fibroid | NA | Status: TERMINATED